A systems‐level study reveals host‐targeted repurposable drugs against SARS‐CoV‐2 infection

Understanding the mechanism of SARS‐CoV‐2 infection and identifying potential therapeutics are global imperatives. Using a quantitative systems pharmacology approach, we identified a set of repurposable and investigational drugs as potential therapeutics against COVID‐19. These were deduced from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fangyuan, Shi, Qingya, Pei, Fen, Vogt, Andreas, Porritt, Rebecca A, Garcia, Gustavo, Gomez, Angela C, Cheng, Mary Hongying, Schurdak, Mark E, Liu, Bing, Chan, Stephen Y, Arumugaswami, Vaithilingaraja, Stern, Andrew M, Taylor, D Lansing, Arditi, Moshe, Bahar, Ivet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328275/
https://www.ncbi.nlm.nih.gov/pubmed/34339582
http://dx.doi.org/10.15252/msb.202110239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328275/
https://www.ncbi.nlm.nih.gov/pubmed/34339582
http://dx.doi.org/10.15252/msb.202110239

Ejemplares similares